Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QPrEP HIV prevention demonstration project
ACTRN12615000032550Phase 4Terminated
- Sponsor
- Cairns and Hinterland Hospital and Health Service
- Start
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of emtricitabine + tenofovir disoproxil in human immunodeficiency virus infection (HIV), sponsored by Cairns and Hinterland Hospital and Health Service. Primary endpoints: Feasibility of PrEP provision through sexual health clinics and general practice services in Queensland, Acceptability of this model of PrEP provision and 1 more. Started Feb 2015; status: terminated.
02
Drugs
emtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on ACTRN12615000032550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000032550.